03 Jun, EOD - Indian

SENSEX 80737.51 (-0.78)

Nifty 50 24542.5 (-0.70)

Nifty Bank 55599.95 (-0.54)

Nifty IT 36814.9 (-0.67)

Nifty Midcap 100 57517.1 (-0.45)

Nifty Next 50 66671.8 (-0.55)

Nifty Pharma 21354.2 (-0.19)

Nifty Smallcap 100 18114.15 (0.10)

03 Jun, EOD - Global

NIKKEI 225 37446.81 (-0.06)

HANG SENG 23512.49 (1.53)

S&P 5998.75 (0.09)


Corporate News

You are Here : Home > News > Corporate News >

(18 Jul 2024, 09:32)

Board of Aurobindo Pharma approves share buyback of up to Rs 750 cr

At meeting held on 18 July 2024


The Board of Aurobindo Pharma at its meeting held on 18 July 2024 has approved buyback of up to 51,36,986 equity shares of the company at a price of Rs 1,460 per share for a aggregate amount of up to Rs 750 crore.
More News
More Company News View Company Information

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +